Skip to content
Dr. Grey AI

Condition

Pancreatitis

Pancreatitis is inflammation of the pancreas, the organ that makes digestive enzymes and insulin; in acute cases, those enzymes switch on inside the gland and digest it. The evidence is strongest for pancreatic enzymes and vitamin D, which address poor digestion and low fat-soluble vitamins, while secretin testing assessed pancreatic function with roughly 79 to 92 percent accuracy. Curcumin raised antioxidant enzymes in only 20 people, so that finding is early.

Sources: PMID 22194487; PMID 24222963

Supplements studied
1
Medicines and peptides
2
Graded outcomes
5
Trials
1
People studied
20

Evidence by supplement

  • Strong
  • Moderate
  • Limited
  • Very limited

1 supplement

Curcumin: outcomes studied for Pancreatitis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Anti-Oxidant Enzyme Profile

Moderate Increase

Improves (the measure goes up)Moderate effect20 people
Oxidative Stress BiomarkersImproves (the measure goes down)6 studies20 people
Pancreatitis SymptomsImproves (the measure goes down)1 study20 people

Studies that measured pancreatitis symptoms

Prescription medicines and peptides studied, for context

These are not supplements. Most need a prescription, and some are research compounds with no approved use. They are listed so the supplement evidence above can be read against them.

2 medicines and peptides

Secretin (ChiRhoStim)

  • Pancreatic Function Assessment: improves
  • Early Pancreatitis Detection: improves
  • MRCP Enhancement: improves
Secretin (ChiRhoStim): outcomes studied for Pancreatitis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Pancreatic Function Assessment

Endoscopic secretin test: peak bicarbonate <80 mEq/L indicates exocrine insufficiency. Normal response: mean peak 100 mEq/L. 79-92% diagnostic accuracy.

Improves (the measure goes up)Large effect14 studies
Early Pancreatitis Detection

S-MRCP detects early-stage reversible chronic pancreatitis. Signal intensity ratio <1.7 has 92% sensitivity, 75% specificity for early disease. Identifies subtle ductal abnormalities.

Improves (the measure goes up)Large effect14 studies
MRCP Enhancement

Secretin-enhanced MRCP increases chronic pancreatitis detection sensitivity from 77% to 89%. Improves ductal visualization 4-fold. NPV increases from 84% to 98%.

Improves (the measure goes up)Large effect12 studies

Sincalide (Kinevac)

  • Pancreatic Enzyme Secretion: improves
Sincalide (Kinevac): outcomes studied for Pancreatitis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Pancreatic Enzyme Secretion

Combined with secretin for pancreatic function testing. Stimulates enzyme (lipase, amylase) secretion into duodenum. Used for duodenal aspirate analysis in chronic pancreatitis evaluation.

Improves (the measure goes up)Large effect6 studies

Key findings

  • Anti-Oxidant Enzyme ProfileCurcuminImproves (the measure goes up)

The Pancreatitis Recovery & Chronic Management Support protocol

2 primary supplements · 7 supporting supplements

  • Pancreatic EnzymesPrescription PERT: 40,000–50,000 lipase units with meals, 20,000–25,000 with snacks
  • Vitamin D2,000–4,000 IU daily (often higher doses needed; monitor levels)

See the full protocol

Shop the evidence-backed picks

Support alongside medical care. These supplements are not a treatment for Pancreatitis. If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.

Fullscript collectionGut and digestion: evidence-graded picksOpen on Fullscript

We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure

Studies cited

100 studies from PubMed

  1. Effect of curcumin on inflammatory markers and disease activity in patients with rheumatoid arthritis: A meta-analysis.Medicine (Baltimore), 2025 · PMID 41327719
  2. Gastrointestinal cholecystokinin signaling pathway drugs modulate osteogenic/cementogenic differentiation of human periodontal ligament stem cells.Journal of dentistry, 2025 · PMID 40032153
  3. The Effect of Antioxidant Polyphenol Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis.Nutrients, 2024 · PMID 39683599
  4. The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD: A Systematic Review and Meta-Analysis.Food Sci Nutr, 2024 · PMID 39723101
  5. Ojeok-san enhances platinum sensitivity in ovarian cancer by regulating adipocyte paracrine IGF1 secretion.Adipocyte, 2024 · PMID 37993991
  6. HDAC1-Mediated Downregulation of NEU1 Exacerbates the Aggressiveness of Cervical Cancer.Critical reviews in eukaryotic gene expression, 2024 · PMID 38505872
  7. All you need to know about gastrinoma today: Gastrinoma and Zollinger-Ellison syndrome: A thorough updateBiochim Biophys Acta Rev Cancer, 2023 · PMID 37042078
  8. Effects of a long-acting secretin peptide analog alone and in combination with a GLP-1R agonist in a diet-induced obesity mouse model.Molecular metabolism, 2023 · PMID 37390979
  9. Defining Biliary Hyperkinesia and the Role of CholecystectomyDig Dis Sci, 2023 · PMID 37366537
  10. Secretin Receptor as a Target in Gastrointestinal Cancer: Expression Analysis and Ligand Development.Biomedicines, 2022 · PMID 35327338
  11. C1QTNF6 Targeted by MiR-184 Regulates the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells.Molecular biotechnology, 2022 · PMID 35578071
  12. Secretin as a Satiation Whisperer With the Potential to Turn into an Obesity-curbing Knight.Endocrinology, 2021 · PMID 34089599
  13. Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?Frontiers in endocrinology, 2021 · PMID 34671320
  14. Cholescintigraphy may have a role in selecting patients with biliary dyskinesia for cholecystectomy: a systematic reviewSurg Endosc, 2020 · PMID 32479706
  15. Utilizing the Cholecystagogue, Ensure Plus, Results in Similar Hepatobiliary Scintigraphy Study Results and Patient Outcomes Status Post Cholecystectomy, in Comparison With Sincalide.Clinical nuclear medicine, 2020 · PMID 31789906
  16. Sincalide: A Review of Clinical Utility, Proper Infusion Methodology, and Alternative Cholecystogogues.Journal of nuclear medicine technology, 2019 · PMID 31019045
  17. Curcumin alleviates postprandial glycaemic response in healthy subjects: A cross-over, randomized controlled studySci Rep, 2018 · PMID 30209353
  18. Substantial Variability Across Individuals in the Vascular and Nutrigenomic Response to an Acute Intake of Curcumin: A Randomized Controlled TrialMol Nutr Food Res, 2018 · PMID 29034576
  19. The clinical value of secretin-enhanced MRCP in the functional and morphological assessment of pancreatic diseasesAbdom Radiol, 2018 · PMID 29206061
  20. Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stressAging (Albany NY), 2017 · PMID 28070018
  21. Novel Form of Curcumin Improves Endothelial Function in Young, Healthy Individuals: A Double-Blind Placebo Controlled StudyJ Nutr Metab, 2016 · PMID 27630772
  22. The Value of Secretin-Enhanced MRCP in Patients With Recurrent Acute PancreatitisAm J Roentgenol, 2016 · PMID 27824485
  23. Secretin-enhanced MR Imaging of the PancreasMagn Reson Imaging Clin N Am, 2016 · PMID 26989929
  24. Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2016 · PMID 26725182
  25. A Phase II Trial of Human Secretin Infusion for Refractory Type B Pain in Chronic Pancreatitis: Erratum.Pancreas, 2016 · PMID 27077722
  26. Diagnostic Performance of Contrast-Enhanced MRI With Secretin-Stimulated MRCP for Non-Calcific Chronic Pancreatitis: A Comparison With HistopathologyAJR Am J Roentgenol, 2015 · PMID 26372506
  27. Endoscopic Pancreatic Function Test using Combined Secretin and Cholecystokinin Stimulation for the Evaluation of Chronic PancreatitisGastrointest Endosc, 2015 · PMID 25773097
  28. Secretin receptor-knockout mice are resistant to high-fat diet-induced obesity and exhibit impaired intestinal lipid absorption.FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014 · PMID 24769669
  29. Pain provocation and low gallbladder ejection fraction with CCK cholescintigraphy are not predictive of chronic acalculous gallbladder disease symptom relief after cholecystectomySurg Endosc, 2014 · PMID 24852884
  30. Classification schema of symptomatic enterogastric reflux utilizing sincalide augmentation on hepatobiliary scintigraphy.Journal of nuclear medicine technology, 2014 · PMID 25033884
  31. Quantification of pancreatic exocrine function of chronic pancreatitis with secretin-enhanced MRCPWorld J Gastroenterol, 2013 · PMID 24222963
  32. A phase II trial of human secretin infusion for refractory type B pain in chronic pancreatitis.Pancreas, 2013 · PMID 23548879
  33. Secretin-enhanced MRCP: review of technique and application with proposal for quantification of exocrine functionAbdom Imaging, 2012 · PMID 22194487
  34. Optimum utilization of cholecystokinin cholescintigraphy (CCK-HIDA) in clinical practice: an evidence based reviewJ Gastrointest Surg, 2012 · PMID 22655428
  35. Dicyclomine: cause of abnormally decreased gall bladder ejection with sincalide-stimulated hepatobiliary scintigraphy.Clinical nuclear medicine, 2012 · PMID 22157036
  36. Effect of different curcuminoid supplement dosages on total in vivo antioxidant capacity and cholesterol levels of healthy human subjectsPhytother Res, 2011 · PMID 21796707
  37. Extragastrointestinal functions and transcriptional regulation of secretin and secretin receptors.Annals of the New York Academy of Sciences, 2011 · PMID 21388401
  38. Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjectsNutr J, 2010 · PMID 20937162
  39. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigenProstate, 2010 · PMID 20503397
  40. Diagnostic efficacy of the secretin stimulation test for the Zollinger-Ellison syndrome: an intra-individual comparison using different dosages in patients and controlsRegul Pept, 2010 · PMID 20299818
  41. Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization.Regulatory peptides, 2010 · PMID 20541569
  42. Sincalide-Stimulated Cholescintigraphy: A Multicenter Investigation to Determine Optimal Infusion Methodology and Gallbladder Ejection Fraction Normal ValuesJ Nucl Med, 2010 · PMID 20124048
  43. Extended application of 99mTc-mebrofenin cholescintigraphy with cholecystokinin in the evaluation of abdominal pain of hepatobiliary and gastrointestinal origin.Nuclear medicine communications, 2010 · PMID 20147863
  44. Diagnostic yield of ERCP and secretin-enhanced MRCP and EUS in patients with acute recurrent pancreatitis of unknown aetiologyGastrointest Endosc, 2009 · PMID 19278909
  45. Gateways to clinical trials.Methods and findings in experimental and clinical pharmacology, 2009 · PMID 19907722
  46. Diagnosis of BD relied in great measure on gallbladder ejection fraction (GBEF) after sincalide stimulation on hepatobiliary scintigraphy.Journal of pediatric surgery, 2009 · PMID 19853777
  47. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week studyDrugs R D, 2008 · PMID 18588355
  48. Biliary dyskinesiaCurr Treat Options Gastroenterol, 2008 · PMID 18992594
  49. Diagnosis of early-stage chronic pancreatitis by secretin-enhanced magnetic resonance cholangiopancreatographyPancreas, 2007 · PMID 17238039
  50. Chili, but not turmeric, inhibits iron absorption in young women from an iron-fortified composite mealJ Nutr, 2006 · PMID 17116705
  51. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials.Research in developmental disabilities, 2005 · PMID 15590241
  52. Rapid endoscopic secretin stimulation test and discrimination of chronic pancreatitis and pancreatic cancer from disease controlsPancreas, 2004 · PMID 15017660
  53. Expression and functions of the duodenal peptide secretin and its receptor in human lung.American journal of respiratory cell and molecular biology, 2004 · PMID 15191914
  54. Secretin as a treatment for autism: a review of the evidence.Journal of autism and developmental disorders, 2004 · PMID 15628608
  55. Laparoscopic cholecystectomy for biliary dyskinesia: correlation of preoperative cholecystokinin cholescintigraphy results with postoperative outcomeSurg Laparosc Endosc Percutan Tech, 2004 · PMID 15054652
  56. Systematic review and meta-analysis: does gall-bladder ejection fraction on cholecystokinin cholescintigraphy predict outcome after cholecystectomy in suspected functional biliary pain?Aliment Pharmacol Ther, 2003 · PMID 12869076
  57. Interactions of human secretin with sterically stabilized phospholipid micelles amplify peptide-induced vasodilation in vivo.Peptides, 2002 · PMID 12182944
  58. Effect of atropine and sincalide on the intestinal uptake of F-18 fluorodeoxyglucose.Clinical nuclear medicine, 1999 · PMID 10595478
  59. Molecular basis and species specificity of high affinity binding of vasoactive intestinal polypeptide by the rat secretin receptor.The Journal of pharmacology and experimental therapeutics, 1996 · PMID 8930157
  60. Cholecystokinin octapeptide (CCK-8): a negative feedback control mechanism for opioid analgesia.Progress in brain research, 1995 · PMID 7568886
  61. Hemobilia presenting as intermittent gastrointestinal hemorrhage with sincalide confirmation. A case report.Clinical nuclear medicine, 1995 · PMID 7628138
  62. Abnormal gallbladder nuclear ejection fraction predicts success of cholecystectomy in patients with biliary dyskinesiaAm J Surg, 1993 · PMID 8273847
  63. Preparation of radioiodinated secretin for radioimmunoassay.Annals of nuclear medicine, 1991 · PMID 1764343
  64. Secretin as a potential mediator of antiulcer actions of mucosal protective agents.Journal of clinical gastroenterology, 1991 · PMID 1940202
  65. Cholecystokinin enhanced hepatobiliary scanning with ejection fraction calculation as an indicator of disease of the gallbladderSurg Gynecol Obstet, 1991 · PMID 1985336
  66. Kinevac (sincalide for injection)/Squibb DiagnosticsRadiology, 1991 · PMID 1932168
  67. Ultrastructural identification of human secretin cells by the immunogold technique. Their costorage of chromogranin A and serotonin.Histochemistry, 1990 · PMID 1972699
  68. Processing of prosecretin: isolation of a secretin precursor from porcine intestine.Proceedings of the National Academy of Sciences of the United States of America, 1990 · PMID 2395872
  69. Sincalide-augmented quantitative hepatobiliary scintigraphy (QHBS): definition of normal parameters and preliminary relationship between QHBS and sphincter of Oddi (SO) manometry in patients suspected of having SO dysfunction.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1990 · PMID 2395012
  70. Secretin provocation test in the diagnosis of Zollinger-Ellison syndromeAnn Intern Med, 1989 · PMID 1992623
  71. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.Cancer research, 1988 · PMID 2842044
  72. Dopamine neuronal tracts in schizophrenia: their pharmacology and in vivo glucose metabolism.Annals of the New York Academy of Sciences, 1988 · PMID 2904785
  73. Cholecystokinin and pain.Pain and headache, 1987 · PMID 3317368
  74. [Secretin and peptic ulcer].Terapevticheskii arkhiv, 1985 · PMID 4002139
  75. Practical hepatobiliary imaging using pretreatment with sincalide in 139 hepatobiliary studies.Clinical nuclear medicine, 1985 · PMID 4017380
  76. Secretin-like immunoreactivity and biological activity in the antral mucosa.Endocrinology, 1983 · PMID 6347663
  77. [Gastrointestinal hormones and related neuropeptides. II. The secretin group: secretin].Postepy higieny i medycyny doswiadczalnej, 1983 · PMID 6387677
  78. Radioimmunoassay of secretin. A critical review and current status.Digestive diseases and sciences, 1980 · PMID 6104568
  79. Radioimmunoassay of secretin.Gastroenterology, 1978 · PMID 648833
  80. Immunoreactive secretin and exocrine pancreatic secretion.Gastroenterology, 1978 · PMID 700332
  81. Radioimmunoassay measurement of secretin half-life in man.Gastroenterology, 1977 · PMID 830238
  82. Immunological aspects of secretin, substance P, and VIP.Gastroenterology, 1977 · PMID 838240
  83. [Radioimmunoassay for secretin].Schweizerische medizinische Wochenschrift, 1977 · PMID 854726
  84. Radioimmunoassay of secretin in plasma.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1976 · PMID 1086282
  85. [Clinical use of secretin (literature review and personal data)].Terapevticheskii arkhiv, 1972 · PMID 4573054
  86. Efficacy of Curcuma longa in relieving pain symptoms of knee osteoarthritis patients: a systematic review and meta-analysis of clinical trials.J Rheum Dis · PMID 39712249
  87. Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trialInflammopharmacology · PMID 27761693
  88. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled studyBMC Complement Altern Med · PMID 29316908
  89. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective studyJ Orthop Sci · PMID 25308211
  90. Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm studyTrials · PMID 30975196
  91. Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trialPhytother Res · PMID 24853120
  92. Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trialInflammopharmacology · PMID 23242572
  93. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patientsAltern Med Rev · PMID 21194249
  94. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter studyClin Interv Aging · PMID 24672232
  95. Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritisPanminerva Med · PMID 20657536
  96. The efficacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trialJ Med Assoc Thai · PMID 23964444
  97. A Randomized, Double Blind, Placebo Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Curene® versus Placebo in Reducing Symptoms of Knee OABiomed Res Int · PMID 30498758
  98. Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritisJ Altern Complement Med · PMID 19678780
  99. Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis.J Ethnopharmacol · PMID 38036015
  100. Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis.BMC Complement Med Ther · PMID 40731001